The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Asacolon 400 mg Gastro-resistant Tablets

400 milligram(s) Gastro-resistant tablet

Imbat LimitedPPA1151/107/001

Main Information

Trade NameAsacolon 400 mg Gastro-resistant Tablets
Active SubstancesMesalazine
Strength400 milligram(s)
Dosage FormGastro-resistant tablet
Licence HolderImbat Limited
Licence NumberPPA1151/107/001

Group Information

ATC CodeA07EC Aminosalicylic acid and similar agents
A07EC02 mesalazine


Withdrawn Date25/08/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back